YH003 is an agonistic anti-CD40 IgG2 monoclonal antibody with best-in-class potential YH003 in combination with…
YH003 is an agonistic anti-CD40 IgG2 monoclonal antibody with best-in-class potential. YH003 in combination with…
MELBOURNE, Australia--(BUSINESS WIRE)--Global fintech Airwallex has embarked on a pivotal partnership with the University of…
ORM-5029 is a first-in-class drug candidate designed to selectively deliver catalytic GSPT1 protein degraders to…
SINGAPORE - Media OutReach - 1 November 2022 - Singapore-based Lightnet Group ("Lightnet") announced today…
INDIANAPOLIS, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Kite Realty Group Trust (NYSE: KRG) announced today…
Boomi helps top Western Australian university make data more accessible for improved staff and student…
TAIPEI, Taiwan--(BUSINESS WIRE)--The Taiwan Textile Federation recently released an explainer video detailing the latest developments…
DUBLIN--(BUSINESS WIRE)--The "Cell Reprogramming Market Share, Size, Trends, Industry Analysis Report, By Technology, By Application,…
DUBLIN--(BUSINESS WIRE)--The "Cold Chain Market in India 2021" report has been added to ResearchAndMarkets.com's offering.…